Not intended for UK and US Media
Ferraté joins the company with the aim of continuing to develop the talent of HIPRA's nearly 3,000 professionals worldwide and supporting the company's international growth
Girona, 2 November, 2026 – HIPRA, a biotechnology pharmaceutical company specialising in the development of vaccines and biological products, has appointed Meritxell Ferraté as Chief People & Organization Officer. Ferraté will lead the people management strategy for the company's nearly 3,000 professionals worldwide, across its 40 subsidiaries, with the aim of fostering talent development, strengthening leadership and continuing to place people at the heart of HIPRA's strategy. She will also contribute to building a strong organisational structure that supports the company's international growth, in line with the values that define HIPRA: excellence, nonconformity and optimism.
With this appointment, HIPRA reaffirms its belief that a company's growth depends not only on innovation and technological capabilities, but also on the people who make it possible. This commitment is reflected in the strengthening of its leadership team and its determination to continue building an organisation ready to face future challenges.
A career focused on transformation and people development
Meritxell Ferraté brings more than 20 years of experience in people management, organisational transformation and talent development in international environments. Throughout her career, she has held senior leadership positions in the pharmaceutical industry, combining a strategic business perspective with a strong people-focused approach.
Most recently, she served as Chief Transformation Officer at Towa International. She holds a degree in Chemistry from the University of Barcelona, a degree in Industrial Technical Engineering from the Polytechnic University of Catalonia, and has completed the General Management Programme (PDG) at IESE Business School.